Esther Landhuis
WGBH
San Francisco Bay Area, CA, United States
Contact Esther
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Esther:
Which type of eye doctor do you need? Optometrists and ophthalmologists face off
This past November, a patient asked optometrist Kaitlin Soracco to remove a bulge of skin on her eyelid. Such skin tags can be excised right there in the office using procedures Soracco studied and observed in optometry school almost a decade ago. Yet in California, where Soracco works, as well as… → Read More
Which type of eye doctor do you need? Optometrists and ophthalmologists face off
Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. But it's more than a turf war, both sides say, as they explain why patients' vision is at stake. → Read More
Which type of eye doctor do you need? Optometrists and ophthalmologists face off
Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. But it's more than a turf war, both sides say, as they explain why patients' vision is at stake. → Read More
Which type of eye doctor do you need? Optometrists and ophthalmologists face off
Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. But it's more than a turf war, both sides say, as they explain why patients' vision is at stake. → Read More
In State Legislatures, The Continuing Battle Over Eye Care
Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. → Read More
What Does ‘Protection’ against COVID Really Mean?
To answer that question, expanded testing is needed that can determine levels of T immune cells → Read More
Here’s Who Should Get a Second COVID Booster
An individual’s health risks, treatment access and local case levels come into play for those who are eligible → Read More
Here’s Who Should Get a Second COVID Booster
An individual’s health risks, treatment access and local case levels come into play for those who are eligible → Read More
Investigating Antidepressants’ Surprising Effect on COVID Deaths
Researchers are still puzzling over what this drug does at the molecular level to help COVID patients → Read More
Scientists Seek Covid Treatment Answers in Cheap, Older Drugs
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions. → Read More
Turning Anger Into Action: Minority Students Analyze COVID Data on Racial Disparities
About 70 college students are enrolled this summer in a program developed by San Francisco researchers and funded by the National Institutes of Health that allows them to explore the pandemic’s imp… → Read More
COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’
Biotechs and pharma want to protect patients without triggering immune system havoc → Read More
Gut Microbes May Be Key to Solving Food Allergies
New therapeutics are testing whether protective bacteria can dampen harmful immune responses to food → Read More
Could gut microbes be key to solving food allergies?
New therapeutics are testing whether protective bacteria can dampen harmful immune responses to food → Read More
‘Spider-Man’ Immune Response May Promote Severe COVID-19
Clinical trials have begun to test drugs that counter toxic molecular webs linked to lung distress → Read More
Why Women May Be More Susceptible to Mood Disorders
New research in mice suggests that a pregnancy hormone contributes to brain and behavioral changes caused by childhood adversity → Read More
Could Newly Found “Peacekeeping” Cells Be a Weapon against COVID-19?
In mice, these white blood cells tamp down inflammation in the lungs → Read More
Allergists debate anticipated FDA approval of a peanut allergy drug
The drug, called Palforzia, was developed by California startup Aimmune Therapeutics to be taken daily in a regimen known as oral immunotherapy. → Read More
Allergists Debate Anticipated FDA Approval Of A Peanut Allergy Drug
Some question the need for a costly pill that's basically made of peanut flour. But with standardized capsules, more peanut allergy sufferers could gain access to a treatment now available to few. → Read More
Why Parents Are Turning to a Controversial Treatment for Food Allergies
A treatment based on a century-old concept could soon receive FDA approval. But will it cause more anxiety than relief? → Read More